April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
April 18, 2024 EU Moves Toward Single Capital Market Union
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
Amazon Web Services Expands Bedrock GenAI Service
Why Microsoft Stands Out As A Pre-Earnings Buy
Wall Street Lunch: Big Tech Bearishness?
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
OKYO Pharma (OKYO) stock forecast for 2026
Updated: April 20, 2024 (07:56)
Sector: HealthcareThe share price of OKYO Pharma Limited (OKYO) now
50/200 Day Moving Average: $1.455 / $1.644
This figure corresponds to the Average Price over the previous 50/200 days. For OKYO Pharma stocks, the 50-day moving average is the resistance level today.
For OKYO Pharma stocks, the 200-day moving average is the resistance level today.
Are you interested in OKYO Pharma Limited stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the OKYO Pharma stock price in 2026. How much will one OKYO Pharma share be worth in 2026? Is it worth taking profit / loss on OKYO stock now or waiting? What are analysts' forecasts for OKYO Pharma stock?
We forecast OKYO Pharma stock performance using neural networks based on historical data on OKYO stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
OKYO Pharma Limited stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for OKYO Pharma analysts is $None. Today 200 Day Moving Average is the resistance level (1.644 $). 50 Day Moving Average is the resistance level (1.455 $).
Historical and forecast chart of OKYO Pharma Limited stock
The chart below shows the historical price of OKYO Pharma stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the OKYO stock price can be found in the table below.
OKYO Pharma Limited operates as a preclinical biopharmaceutical company in the United Kingdom. Its preclinical development program includes OK-101 for the treatment of dry eyes, uveitis, and allergic conjunctivitis; and OK-201 to treat corneal neuropathic pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome (ARDS). OKYO Pharma Limited was incorporated in 2018 and is headquartered in London, the United Kingdom.
OKYO Pharma (OKYO) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.61 | 0.55 | 0.73 | 24.27 % |
| Feb | 0.62 | 0.51 | 0.66 | 22.72 % |
| Mar | 0.52 | 0.48 | 0.60 | 19.04 % |
| Apr | 0.46 | 0.41 | 0.53 | 23.44 % |
| May | 0.45 | 0.37 | 0.53 | 30.79 % |
| Jun | 0.44 | 0.42 | 0.53 | 20.96 % |
| Jul | 0.49 | 0.41 | 0.55 | 26.10 % |
| Aug | 0.46 | 0.42 | 0.48 | 13.27 % |
| Sep | 0.50 | 0.47 | 0.57 | 17.40 % |
| Oct | 0.52 | 0.48 | 0.60 | 20.30 % |
| Nov | 0.51 | 0.43 | 0.58 | 25.76 % |
| Dec | 0.58 | 0.51 | 0.65 | 20.40 % |
OKYO Pharma information and performance
MARTELLO COURT, ADMIRAL PARK, ST. PETER PORT, GG
Market capitalization of the OKYO Pharma Limited is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of OKYO shares in the company outstanding by the market price of one share.
EBITDA of OKYO Pharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
OKYO Pharma price target for 2026 by month
Target values for the price of one OKYO Pharma share for Jan 2026.
In Jan, the Negative dynamics for OKYO Pharma Limited shares will prevail with possible monthly volatility of 24.268% volatility is expected.
Pessimistic target level: 0.55
Optimistic target level: 0.73
Target values for the price of one OKYO Pharma share for Feb 2026.
In Feb, the Positive dynamics for OKYO Pharma Limited shares will prevail with possible monthly volatility of 22.717% volatility is expected.
Pessimistic target level: 0.51
Optimistic target level: 0.66
Target values for the price of one OKYO Pharma share for Mar 2026.
In Mar, the Negative dynamics for OKYO Pharma Limited shares will prevail with possible monthly volatility of 19.037% volatility is expected.
Pessimistic target level: 0.48
Optimistic target level: 0.60
Target values for the price of one OKYO Pharma share for Apr 2026.
In Apr, the Negative dynamics for OKYO Pharma Limited shares will prevail with possible monthly volatility of 23.441% volatility is expected.
Pessimistic target level: 0.41
Optimistic target level: 0.53
Target values for the price of one OKYO Pharma share for May 2026.
In May, the Negative dynamics for OKYO Pharma Limited shares will prevail with possible monthly volatility of 30.786% volatility is expected.
Pessimistic target level: 0.37
Optimistic target level: 0.53
Target values for the price of one OKYO Pharma share for Jun 2026.
In Jun, the Negative dynamics for OKYO Pharma Limited shares will prevail with possible monthly volatility of 20.964% volatility is expected.
Pessimistic target level: 0.42
Optimistic target level: 0.53
Target values for the price of one OKYO Pharma share for Jul 2026.
In Jul, the Positive dynamics for OKYO Pharma Limited shares will prevail with possible monthly volatility of 26.097% volatility is expected.
Pessimistic target level: 0.41
Optimistic target level: 0.55
Target values for the price of one OKYO Pharma share for Aug 2026.
In Aug, the Negative dynamics for OKYO Pharma Limited shares will prevail with possible monthly volatility of 13.270% volatility is expected.
Pessimistic target level: 0.42
Optimistic target level: 0.48
Target values for the price of one OKYO Pharma share for Sep 2026.
In Sep, the Positive dynamics for OKYO Pharma Limited shares will prevail with possible monthly volatility of 17.401% volatility is expected.
Pessimistic target level: 0.47
Optimistic target level: 0.57
Target values for the price of one OKYO Pharma share for Oct 2026.
In Oct, the Positive dynamics for OKYO Pharma Limited shares will prevail with possible monthly volatility of 20.302% volatility is expected.
Pessimistic target level: 0.48
Optimistic target level: 0.60
Target values for the price of one OKYO Pharma share for Nov 2026.
In Nov, the Negative dynamics for OKYO Pharma Limited shares will prevail with possible monthly volatility of 25.764% volatility is expected.
Pessimistic target level: 0.43
Optimistic target level: 0.58
Target values for the price of one OKYO Pharma share for Dec 2026.
In Dec, the Positive dynamics for OKYO Pharma Limited shares will prevail with possible monthly volatility of 20.404% volatility is expected.
Pessimistic target level: 0.51
Optimistic target level: 0.65
